+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Culture Test Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Blood Culture Test Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Blood Culture Test Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995116
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Culture Test Market grew from USD 4.49 billion in 2024 to USD 4.78 billion in 2025. It is expected to continue growing at a CAGR of 6.21%, reaching USD 6.44 billion by 2030.

Blood culture testing stands at the forefront of clinical diagnostics, providing critical insights into bloodstream infections and guiding targeted antimicrobial therapy. As sepsis and bacteremia remain leading causes of morbidity and mortality worldwide, the accuracy and speed of blood culture assays have never been more essential. Healthcare providers rely on timely detection of pathogens to optimize patient outcomes, mitigate antibiotic resistance, and streamline hospital workflows. In tandem with rising regulatory expectations and reimbursement pressures, laboratories face the dual challenge of enhancing diagnostic performance while managing operational efficiency. Recent advances in automation and molecular methodologies have begun to reshape traditional workflows, offering the promise of faster turnaround times and more precise identification of organisms. Moreover, the escalating focus on antimicrobial stewardship programs amplifies demand for rapid susceptibility profiling, positioning blood culture platforms as pivotal tools in the battle against multidrug-resistant infections. Against this dynamic backdrop, industry leaders and decision-makers must navigate a complex ecosystem of evolving technologies, shifting regulatory landscapes, and changing clinical needs to remain responsive and competitive.

Transformative Shifts Redefining Blood Culture Diagnostics

Over the past decade, transformative shifts have redefined the blood culture diagnostics landscape, ushering in an era of unprecedented precision and speed. First, automation has expanded beyond basic incubation to encompass end-to-end sample handling, from automated inoculation systems to integrated digital monitoring. These enhancements reduce manual intervention, minimize contamination risks, and deliver actionable results more rapidly. In parallel, the emergence of molecular techniques-such as loop-mediated isothermal amplification (LAMP), peptide nucleic acid (PNA) probes, and polymerase chain reaction (PCR)-has elevated pathogen detection to a new level, enabling direct identification from positive culture bottles. Additionally, advanced analytics driven by machine learning algorithms now interpret growth curves and predict resistance patterns, empowering laboratories to preemptively adjust therapeutic regimens. Point-of-care platforms and decentralization efforts have further extended testing capabilities into community settings, offering on-site diagnostics with near-lab accuracy. Together, these developments are not only accelerating diagnosis but also fostering personalized treatment strategies, ultimately improving patient outcomes and optimizing resource utilization across healthcare systems.

Cumulative Impact of United States Tariffs in 2025

The implementation of new United States tariffs in 2025 has introduced a series of downstream effects across the blood culture testing supply chain. Imported instruments, including automated blood culture systems and spectrophotometric detectors, have become subject to elevated duties, prompting suppliers to reassess manufacturing footprints and logistics strategies. As a result, reagent costs have increased, exerting pressure on hospital laboratories and reference facilities to renegotiate pricing agreements and adopt inventory optimization practices. In response, several global manufacturers have initiated partial repatriation of production to mitigate duty exposure, while others are exploring tariff exclusion requests to preserve affordability. Moreover, service contracts have been recalibrated to account for higher spare-parts expense, leading end users to consider multi-vendor maintenance frameworks to ensure continuity of operations. The cumulative impact of these tariffs underscores the importance of proactive supply-chain diversification: by forging partnerships with local producers, aligning procurement schedules with tariff phases, and leveraging bonded warehousing solutions, industry stakeholders can alleviate cost burdens and maintain consistent access to critical diagnostics.

Key Segmentation Insights Across Test Types, Applications, and More

A nuanced understanding of blood culture test market segmentation reveals distinct drivers and adoption patterns across technologies and end uses. Based on test type, the landscape divides into conventional and molecular techniques, where the former encompasses automated systems-featuring platforms like BacT/ALERT 3D, BacT/ALERT, BacT/ALERT Virtuo, and BD BACTEC FX-and manual methods, while the latter includes isothermal amplification via LAMP, PNA-based assays, and classic PCR protocols. In terms of application, the focus splits between clinical testing and research, with the clinical arm addressing bacteremia and stratified sepsis cases-from adult to pediatric, then further into infant and neonatal sepsis-while research applications concentrate on drug resistance studies and foundational pathogen investigations. End users span hospital laboratories and reference laboratories, the latter comprising both commercial and public health entities. From a technology perspective, centrifugation remains integral for sample processing, whereas spectrophotometric detection leverages colorimetric and turbidimetric approaches for growth monitoring. Product segmentation singles out instruments, distinguishing automated blood culture platforms from conventional manual instruments. Finally, microorganism type categorization covers fungi-including molds and yeasts-and both gram-negative and gram-positive bacteria, each segment presenting unique diagnostic challenges and development priorities.

Key Regional Insights Shaping Global Blood Culture Trends

Regional dynamics shape the global uptake of blood culture diagnostics, with the Americas leading in both installed base of automated systems and adoption of molecular platforms, driven by robust healthcare infrastructure and strong research funding. Meanwhile, Europe, Middle East & Africa exhibit heterogeneity: Western Europe maintains high compliance with regulatory harmonization initiatives and continues to prioritize rapid diagnostic integration, whereas emerging markets in the Middle East and Africa present growth opportunities through public health laboratories and targeted sepsis surveillance programs. In the Asia-Pacific region, expanding healthcare access and rising prevalence of infectious diseases have accelerated demand for cost-efficient instruments; local manufacturers complement global suppliers by focusing on adaptable solutions tailored to regional needs. Cross-regional collaborations, including technology transfer agreements and multi-market clinical validation studies, further facilitate knowledge exchange and help harmonize performance standards-ensuring that innovations migrate swiftly across continents and deliver consistent benefits to patients worldwide.

Key Company Insights Highlighting Industry Leaders and Innovators

Industry leadership is defined by both technological innovation and strategic agility, as demonstrated by a diverse roster of prominent players. Abbott Laboratories and Anaerobe Systems, Inc. have enhanced their pathogen detection portfolios, while Autobio Diagnostics Co., Ltd. and Becton, Dickinson and Company drive breakthroughs in end-to-end automation. BINDER GmbH focuses on precision incubation, and Biobase Biodusty (Shandong) Co., Ltd. addresses cost-effective solutions for emerging markets. Biomérieux SA continues to lead in molecular assay development, and Bruker Corporation integrates mass spectrometry to accelerate microbial identification. Danaher Corporation leverages digital connectivity for performance analytics, while Devyser AB specializes in customizable pathogen kits. Pharmaceutical innovators like Eli Lilly and Company engage in drug resistance research, complemented by F. Hoffmann-La Roche Ltd.’s efforts in next-generation assay platforms. HiMedia Laboratories Pvt. Ltd. supplies advanced culture media, and Juno Diagnostics, Inc. pioneers point-of-care testing. Neogen Corporation supports quality control programs, and Novartis AG explores novel antimicrobial targets. Bioinformatics collaborations among OpGen, Inc. and Scenker Biological Technology Co., Ltd. enhance genomic insights. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Siemens Healthineers AG expand automated instrument offerings, while T2 Biosystems, Inc. introduces rapid detection modules. Terumo Corporation refines sample handling, Thermo Fisher Scientific, Inc. delivers comprehensive reagent ecosystems, and ZeptoMetrix Corporation ensures proficiency testing standards.

Actionable Recommendations for Industry Leaders in Blood Culture Testing

To capitalize on emerging opportunities and circumvent supply-chain disruptions, industry leaders should pursue the following strategic actions: 1. Invest in modular molecular platforms that can be rapidly reconfigured to detect novel pathogens and resistance markers, ensuring agility against evolving infectious threats. 2. Diversify supply networks by qualifying multiple local and international vendors, securing raw materials and critical components to buffer against tariff fluctuations and geopolitical risks. 3. Align product development with global regulatory harmonization efforts, proactively engaging with authorities to streamline approval pathways and expedite market entry. 4. Integrate digital health solutions-such as cloud-based data analytics and predictive maintenance-to enhance instrument uptime, optimize lab workflows, and provide real-time decision support. 5. Forge strategic alliances with academic and public health institutions to co-develop point-of-care diagnostics, leveraging shared expertise to address unmet clinical needs in underserved regions. 6. Prioritize antimicrobial resistance research by partnering with pharmaceutical and biotechnology companies, facilitating joint development of companion diagnostics that inform targeted therapy. 7. Emphasize user-centric design through continuous feedback loops with end users, ensuring that instrument interfaces and workflows align with laboratory best practices and evolving clinical demands.

Conclusion: Navigating the Future of Blood Culture Diagnostics

In summary, the blood culture testing ecosystem is undergoing rapid evolution, driven by technological breakthroughs, shifting regulatory landscapes, and strategic realignments in response to tariff pressures. Automation and molecular diagnostics have expanded the capabilities of clinical and research laboratories alike, demanding that stakeholders remain nimble and forward-thinking. Regional variations-from the Americas’ advanced infrastructures to the Asia-Pacific’s emerging manufacturing hubs-underscore the necessity of tailored approaches that respect local healthcare dynamics. Meanwhile, leading companies illustrate the power of innovation, partnership, and diversification in maintaining competitive advantage. By implementing the recommended strategies-spanning supply-chain resilience, regulatory engagement, digital integration, and collaborative research-organizations can not only navigate current challenges but also shape the future of sepsis management and antimicrobial stewardship. Ultimately, a unified focus on rapid, accurate diagnostics will drive better patient outcomes, optimize resource allocation, and reinforce the critical role of blood culture testing in modern healthcare.

Market Segmentation & Coverage

This research report categorizes the Blood Culture Test Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Conventional Technique
    • Automated Systems
      • BacT/ALERT 3D
      • BacT/ALERT System
      • BacT/ALERT Virtuo
      • BD BACTEC FX
    • Manual Methods
  • Molecular Technique
    • Loop-Mediated Isothermal Amplification (LAMP)
    • Peptide Nucleic Acid (PNA)
    • Polymerase Chain Reaction (PCR)
  • Clinical Testing
    • Bacteremia
    • Sepsis
      • Adult Sepsis
      • Pediatric Sepsis
        • Infant Sepsis
        • Neonatal Sepsis
  • Research Applications
    • Drug Resistance Studies
    • Pathogen Research
  • Hospital Laboratories
  • Reference Laboratories
    • Commercial Reference Laboratories
    • Public Health Laboratories
  • Centrifugation
  • Spectrophotometric Detection
    • Colorimetric Methods
    • Turbidimetric Methods
  • Instruments
    • Automated Blood Culture Instruments
    • Conventional Blood Culture Instruments
  • Fungi
    • Molds
    • Yeasts
  • Gram-Negative Bacteria
  • Gram-Positive Bacteria

This research report categorizes the Blood Culture Test Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Blood Culture Test Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Anaerobe Systems, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • BINDER GmbH
  • Biobase Biodusty(Shandong), Co., Ltd.
  • Biomérieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Devyser AB
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • HiMedia Laboratories Pvt. Ltd.
  • Juno Diagnostics, Inc.
  • Neogen Corporation
  • Novartis AG
  • OpGen, Inc.
  • Scenker Biological Technology Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • T2 Biosystems, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Culture Test Market, by Test Type
8.1. Introduction
8.2. Conventional Technique
8.2.1. Automated Systems
8.2.1.1. BacT/ALERT 3D
8.2.1.2. BacT/ALERT System
8.2.1.3. BacT/ALERT Virtuo
8.2.1.4. BD BACTEC FX
8.2.2. Manual Methods
8.3. Molecular Technique
8.3.1. Loop-Mediated Isothermal Amplification (LAMP)
8.3.2. Peptide Nucleic Acid (PNA)
8.3.3. Polymerase Chain Reaction (PCR)
9. Blood Culture Test Market, by Application
9.1. Introduction
9.2. Clinical Testing
9.2.1. Bacteremia
9.2.2. Sepsis
9.2.2.1. Adult Sepsis
9.2.2.2. Pediatric Sepsis
9.2.2.2.1. Infant Sepsis
9.2.2.2.2. Neonatal Sepsis
9.3. Research Applications
9.3.1. Drug Resistance Studies
9.3.2. Pathogen Research
10. Blood Culture Test Market, by End User
10.1. Introduction
10.2. Hospital Laboratories
10.3. Reference Laboratories
10.3.1. Commercial Reference Laboratories
10.3.2. Public Health Laboratories
11. Blood Culture Test Market, by Technology
11.1. Introduction
11.2. Centrifugation
11.3. Spectrophotometric Detection
11.3.1. Colorimetric Methods
11.3.2. Turbidimetric Methods
12. Blood Culture Test Market, by Product
12.1. Introduction
12.2. Instruments
12.2.1. Automated Blood Culture Instruments
12.2.2. Conventional Blood Culture Instruments
13. Blood Culture Test Market, by Microorganism Type
13.1. Introduction
13.2. Fungi
13.2.1. Molds
13.2.2. Yeasts
13.3. Gram-Negative Bacteria
13.4. Gram-Positive Bacteria
14. Americas Blood Culture Test Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Blood Culture Test Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Blood Culture Test Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Anaerobe Systems, Inc.
17.3.3. Autobio Diagnostics Co., Ltd.
17.3.4. Becton, Dickinson and Company
17.3.5. BINDER GmbH
17.3.6. Biobase Biodusty(Shandong), Co., Ltd.
17.3.7. Biomérieux SA
17.3.8. Bruker Corporation
17.3.9. Danaher Corporation
17.3.10. Devyser AB
17.3.11. Eli Lilly and Company
17.3.12. F. Hoffmann-La Roche Ltd.
17.3.13. HiMedia Laboratories Pvt. Ltd.
17.3.14. Juno Diagnostics, Inc.
17.3.15. Neogen Corporation
17.3.16. Novartis AG
17.3.17. OpGen, Inc.
17.3.18. Scenker Biological Technology Co., Ltd.
17.3.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.3.20. Siemens Healthineers AG
17.3.21. T2 Biosystems, Inc.
17.3.22. Terumo Corporation
17.3.23. Thermo Fisher Scientific, Inc.
17.3.24. ZeptoMetrix Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BLOOD CULTURE TEST MARKET MULTI-CURRENCY
FIGURE 2. BLOOD CULTURE TEST MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD CULTURE TEST MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACT/ALERT 3D, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACT/ALERT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACT/ALERT VIRTUO, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BD BACTEC FX, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MANUAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP), BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PEPTIDE NUCLEIC ACID (PNA), BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY BACTEREMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY ADULT SEPSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INFANT SEPSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY NEONATAL SEPSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY DRUG RESISTANCE STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PATHOGEN RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COMMERCIAL REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COLORIMETRIC METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TURBIDIMETRIC METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED BLOOD CULTURE INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL BLOOD CULTURE INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY YEASTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 112. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 114. CANADA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 116. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. CANADA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 118. CANADA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 119. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 120. CANADA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 121. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. CANADA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 123. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. CANADA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 125. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. CANADA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 127. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 128. CANADA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 199. CHINA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. CHINA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 201. CHINA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 202. CHINA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 203. CHINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. CHINA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 205. CHINA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 206. CHINA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 207. CHINA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 208. CHINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. CHINA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 210. CHINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. CHINA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 212. CHINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. CHINA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. CHINA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 215. CHINA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 216. INDIA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 217. INDIA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 218. INDIA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 219. INDIA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 220. INDIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. INDIA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 222. INDIA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 223. INDIA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 224. INDIA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 225. INDIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. INDIA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 227. INDIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. INDIA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 229. INDIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. INDIA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. INDIA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 232. INDIA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 249. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 250. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 251. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 252. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 254. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 256. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 258. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 259. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 261. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 263. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 265. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 266. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 275. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 276. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 278. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 280. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 281. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 282. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 283. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 300. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 314. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 316. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 317. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 322. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 324. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 325. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY PEDIATRIC SEPSIS, 2018-2030 (USD MILLION)
TABLE 326. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 327. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 329. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY SPECTROPHOTOMETRIC DETECTION, 2018-2030 (USD MILLION)
TABLE 331. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 332. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 333. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY MICROORGANISM TYPE, 2018-2030 (USD MILLION)
TABLE 334. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY FUNGI, 2018-2030 (USD MILLION)
TABLE 335. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 336. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY CONVENTIONAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 337. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 338. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 339. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY CLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

  • Abbott Laboratories
  • Anaerobe Systems, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • BINDER GmbH
  • Biobase Biodusty(Shandong), Co., Ltd.
  • Biomérieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Devyser AB
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • HiMedia Laboratories Pvt. Ltd.
  • Juno Diagnostics, Inc.
  • Neogen Corporation
  • Novartis AG
  • OpGen, Inc.
  • Scenker Biological Technology Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • T2 Biosystems, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Blood Culture Test Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User - Product Image

Blood Culture Test Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • Report
  • 142 Pages
  • Global
From
Blood Culture Tests Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Culture Tests Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 157 Pages
  • Global
From
Blood Culture Test Market Report by Testing Method, Product, Technology, Application, End User, and Region 2024-2032 - Product Image

Blood Culture Test Market Report by Testing Method, Product, Technology, Application, End User, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Blood Culture Tests - Global Strategic Business Report - Product Image

Blood Culture Tests - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Blood Culture Tests Market Report 2025 - Product Image

Blood Culture Tests Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.